ZIAGEN 20 mg/ml, oral solution bottle, 240 ml
Active ingredients: Abacavir sulfate, Abacavir
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 240 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZIAGEN 20 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 240 ml avec seringue(s) doseuse(s) polypropylène polyéthylène
- Marketing authorisation holder
- VIIV HEALTHCARE UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Dec 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62070450CIP73610905CIP133400936109056Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ABACAVIR BASEsolution | 20 mg · 1 ml de solution | FT |
| ABACAVIR (SULFATE D')solution | 23,4 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.